Skanska Signs Anchor for Cambridge Biotech

CAMBRIDGE, MA-Foundation Medicine Inc. has signed on as the anchor tenant for 150 Second St., a three-story office and lab building here developed by Skanska USA Commercial Development Inc. The tenant, which uses genomic analysis to help doctors identify targeted cancer treatments, expects to move into 61,591 square feet at 150 Second in September.

The site will house Foundation Medicine’s clinical laboratory as well as its research laboratory and commercial offices. Completed this past December, 150 Second represents Skanska’s first commercial development in Cambridge, among the Boston area’s leading biotechnology centers. Skanska acquired the property in November of 2010 and self-financed 100% of the development costs.